Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03095352
Title Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hope Rugo, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.